-
South Africa: South Africa Reaches Deal With India to Boost Domestic Vaccine Production
VOA, 2 September 2022
The Serum Institute of India signed a deal this week with South Africa's Aspen Pharmacare to make four vaccines used in Africa. Read more »
-
South Africa: Covid-19 - Benefits of Vaccines Still Far Outweigh Risks, Experts Say
spotlight, 16 August 2022
The benefits of vaccines still far outweigh the risks, experts say following the recently reported death linked to a COVID-19 vaccine. Read more »
-
South Africa: Analysis - Vaccine Partnership With U.S. Government Boosts Prospects for Local Production
spotlight, 25 July 2022
It has been just over a year since the World Health Organization (WHO) announced the selection of Afrigen Biologics, a Cape Town-based biotechnology company, to host its ambitious… Read more »
-
South Africa: Covid-19 - the Role of Next-Generation Vaccines in Immunity
spotlight, 15 July 2022
Since its discovery in November, the Omicron variant of SARS-CoV-2 (the virus that causes COVID-19) has continued to adapt and evolve at an extremely fast pace to evade the body's… Read more »
-
South Africa: African-Based COVID-19 Vaccine On the Cards Through Technology Transfer Hub in Cape Town
RFI, 21 June 2022
In an effort to even the playing field in terms of vaccine delivery and production, a collaboration between South African-based consortium Afrigen Biologics and Belgium-based… Read more »
-
South Africa: Trade, Industry and Competition On World Trade Organisation Landmark Agreement
Govt of SA, 18 June 2022
SA Government, local vaccine producers and labour Welcome WTO landmark agreement that will boost vaccine manufacturers in the developing world Read more »
-
South Africa: EU's Departing Ambassador to SA Reflects On Ukraine, Covid-19, Energy Transition and Trade
Daily Maverick, 19 June 2022
European Union ambassador Riina Kionka is leaving South Africa after a tour marked by expanded trade and major support for South Africa's just energy transition and vaccine… Read more »
South Africa, India Deal to Boost Local Covid-19 Vaccine Assembly
The Serum Institute of India signed a deal with South Africa's Aspen Pharmacare to make four vaccines used in Africa, Vicky Stark writes for Voice of America.
The deal has been hailed as saving local vaccine production, which was at risk of shutting down after receiving no orders for a Covid-19 vaccine. But medical aid group Doctors Without Borders says more efforts are needed for vaccines to be fully produced in Africa for Africans.
Four routine paediatric vaccines will be made in South Africa with products from bulk drug substances supplied by India's Serum Institute.
As of September 5, 2022, a total of 12,141,015 cases of Covid-19 has been confirmed in Africa of which 256,356 proved fatal and 10,378,407 resulted in recovery. Vaccinations administered to date amount to 375,080,700.
InFocus
-
In the absence of orders or commitments, Covid-19 vaccine manufacturer Aspen is considering the repurposing of two Covid-19 production lines for the manufacture of other products, ... Read more »
-
Just under a third of South Africa's remaining Covid-19 vaccines from Pfizer are set to expire by July 2022. After that, any unused doses will have to be destroyed. Until then the Read more »
-
The World Health Organization Director-General Tedros Adhanom Ghebreyesus has fought hard for vaccine equity in the battle against Covid-19. On February 11, 2022 a visit to Read more »
